INS and type 2 diabetes mellitus: When compared to patients who planned to start first-time insulin therapy [15] or those using oral hypoglycemic agents (OHA) alone [16], the following features were observed in this cohort: better glycemic control than patients considering insulin injections [15], but not better than those using OHA alone [16]; younger; shorter duration of T2DM; and higher BMI [19].